This CTD dossier owner and manufacturer was founded in 2007 and has two manufacturing facilities strategically located in India. They boast over 1,800 products spanning a range of therapeutic areas, including those focused on dermatology, pain management, and possibly central nervous system disorders based on the listed divisions. The company produces both prescription medications and over-the-counter drugs, utilizing diverse dosage forms such as tablets and capsules. They maintain a strong national network for distribution and a global presence. GMP certifications are likely held due to their focus on quality manufacturing practices.

This CTD dossier owner and manufacturer is a progressive pharmaceutical manufacturer in India, specializing in the development, manufacturing, and marketing of pharmaceutical, OTC, and nutraceutical products. With a focus on innovation, simplicity, and cost-efficiency, the company aims to deliver high-quality healthcare solutions across India and is planning to expand globally. Committed to providing excellent quality products, the company adheres to strict standards certified by organizations like WHO, US-FDA, GMP, and ISO 9001. With a strong emphasis on quality, Viribus Healthcare ensures that its products are reliable and safe for end users, establishing itself as a trusted name in the pharmaceutical industry.

This pharmaceutical company focuses on developing and manufacturing high-quality products across a range of therapeutic areas to improve global health and well-being. Their portfolio includes prescription medications, over-the-counter drugs, and supplements. Key therapy areas include mental health, cardiovascular disease, and diabetes. Principal dosage forms include tablets and capsules. The company holds GMP certifications, demonstrating adherence to stringent quality standards. They also possess product patents, safeguarding their innovative formulations. Production lines are situated in a region known for its pharmaceutical manufacturing capabilities, serving both the EU and North America markets.